128
H. Zhu et al.
213. Ali A, Sidorova TS, Matesic DF (2013) Dual modulation of JNK and Akt signaling pathways
by chaetoglobosin K in human lung carcinoma and ras-transformed epithelial cells. Invest
New Drugs 31:525
214. Li B, Gao Y, Rankin GO, Rojanasakul Y, Cutler SJ, Tu Y, Chen YC (2015) Chaetoglobosin
K induces apoptosis and G2 cell cycle arrest through p53-dependent pathway in cisplatinresistant ovarian cancer cells. Cancer Lett 356:418
215. Luo H, Li B, Li Z, Cutler SJ, Rankin GO, Chen YC (2013) Chaetoglobosin K inhibits tumor
angiogenesis through downregulation of vascular epithelial growth factor-binding hypoxiainducible factor 1α. Anti-Cancer Drugs 24:715
216. Kolber MA, Hill P (1992) Vincristine potentiates cytochalasin B-induced DNA fragmentation
in vitro. Cancer Chemother Pharmacol 30:286
217. Trendowski M, Wong V, Zoino JN, Christen TD, Gadeberg L, Sansky M, Fondy TP (2015)
Preferential enlargement of leukemia cells using cytoskeletal-directed agents and cell cycle
growth control parameters to induce sensitivity to low frequency ultrasound. Cancer Lett
360:160
218. Trendowski M, Mitchell JM, Corsette CM, Acquafondata C, Fondy TP (2015) Chemotherapy
with cytochalasin congeners in vitro and in vivo against murine models. Invest New Drugs
33:290
219. Trendowski M, Yu GW, Wong V, Acquafondata C, Christen T, Fondy TP (2014) The real
deal: using cytochalasin B in sonodynamic therapy to preferentially damage leukemia cells.
Anticancer Res 34:2195
220. Trendowski M, Christen TD, Acquafondata C, Fondy TP (2015) Effects of cytochalasin
congeners, microtubule-directed agents, and doxorubicin alone or in combination against
human ovarian carcinoma cell lines in vitro. BMC Cancer 15:632
221. Udagawa T, Yuan J, Panigrahy D, Chang YH, Shah J, D’Amato RJ (2000) Cytochalasin E, an
epoxide containing Aspergillus-derived fungal metabolite, inhibits angiogenesis and tumor
growth. J Pharmacol Exp Ther 294:421
222. Stehn JR, Schevzov G, O’Neill GM, Gunning PW (2006) Specialisation of the tropomyosin
composition of actin filaments provides new potential targets for chemotherapy. Curr Cancer
Drug Targets 6:245
223. Qin JC, Zhang YM, Gao JM, Bai MS, Yang SX, Laatsch H, Zhang AL (2009) Bioactive
metabolites produced by Chaetomium globosum, an endophytic fungus isolated from Ginkgo
biloba. Bioorg Med Chem Lett 19:1572
224. Shanthiyaa V, Karthikeyan G, Raguchander T (2014) Production of extracellular proteins,
cellulases and antifungal metabolites by Chaetomium globosum Kunze ex. Fr. Arch
Phytopathol Plant Prot 47:517
225. Zhang G, Wang F, Qin J, Wang D, Zhang J, Zhang Y, Zhang S, Pan H (2013) Efficacy
assessment of antifungal metabolites from Chaetomium globosum No.05, a new biocontrol
agent, against Setosphaeria turcica. Biol Control 64:90
226. Flewelling AJ, Bishop AI, Johnson JA, Gray CA (2015) Polyketides from an endophytic
Aspergillus fumigatus isolate inhibit the growth of Mycobacterium tuberculosis and MRSA.
Nat Prod Commun 10:1661
227. Makioka A, Kumagai M, Kobayashi S, Takeuchi T (2004) Different effects of cytochalasins
on the growth and differentiation of Entamoeba invadens. Parasitol Res 93:68
228. Mori M, Tsuge S, Fukasawa W, Jeelani G, Nakada-Tsukui K, Nonaka K, Matsumoto A,
Omura S, Nozaki T, Shiomi K (2018) Discovery of antiamebic compounds that inhibit cysteine
synthase from the enteric parasitic protist Entamoeba histolytica by screening of microbial
secondary metabolites. Front Cell Infect Microbiol 8:409
229. Masi M, Cimmino A, Tabanca N, Becnel JJ, Bloomquist JR, Evidente A (2017) A survey of
bacterial, fungal and plant metabolites against Aedes aegypti (Diptera: Culicidae), the vector
of yellow and dengue fevers and Zika virus. Open Chem 15:156
230. Hu Y, hang W, Zhang P, Ruan W, Zhu X (2013) Nematicidal activity of chaetoglobosin A
produced by Chaetomium globosum NK102 against Meloidogyne incognita. J Agric Food
Chem 61:41
H. Zhu et al.
213. Ali A, Sidorova TS, Matesic DF (2013) Dual modulation of JNK and Akt signaling pathways
by chaetoglobosin K in human lung carcinoma and ras-transformed epithelial cells. Invest
New Drugs 31:525
214. Li B, Gao Y, Rankin GO, Rojanasakul Y, Cutler SJ, Tu Y, Chen YC (2015) Chaetoglobosin
K induces apoptosis and G2 cell cycle arrest through p53-dependent pathway in cisplatinresistant ovarian cancer cells. Cancer Lett 356:418
215. Luo H, Li B, Li Z, Cutler SJ, Rankin GO, Chen YC (2013) Chaetoglobosin K inhibits tumor
angiogenesis through downregulation of vascular epithelial growth factor-binding hypoxiainducible factor 1α. Anti-Cancer Drugs 24:715
216. Kolber MA, Hill P (1992) Vincristine potentiates cytochalasin B-induced DNA fragmentation
in vitro. Cancer Chemother Pharmacol 30:286
217. Trendowski M, Wong V, Zoino JN, Christen TD, Gadeberg L, Sansky M, Fondy TP (2015)
Preferential enlargement of leukemia cells using cytoskeletal-directed agents and cell cycle
growth control parameters to induce sensitivity to low frequency ultrasound. Cancer Lett
360:160
218. Trendowski M, Mitchell JM, Corsette CM, Acquafondata C, Fondy TP (2015) Chemotherapy
with cytochalasin congeners in vitro and in vivo against murine models. Invest New Drugs
33:290
219. Trendowski M, Yu GW, Wong V, Acquafondata C, Christen T, Fondy TP (2014) The real
deal: using cytochalasin B in sonodynamic therapy to preferentially damage leukemia cells.
Anticancer Res 34:2195
220. Trendowski M, Christen TD, Acquafondata C, Fondy TP (2015) Effects of cytochalasin
congeners, microtubule-directed agents, and doxorubicin alone or in combination against
human ovarian carcinoma cell lines in vitro. BMC Cancer 15:632
221. Udagawa T, Yuan J, Panigrahy D, Chang YH, Shah J, D’Amato RJ (2000) Cytochalasin E, an
epoxide containing Aspergillus-derived fungal metabolite, inhibits angiogenesis and tumor
growth. J Pharmacol Exp Ther 294:421
222. Stehn JR, Schevzov G, O’Neill GM, Gunning PW (2006) Specialisation of the tropomyosin
composition of actin filaments provides new potential targets for chemotherapy. Curr Cancer
Drug Targets 6:245
223. Qin JC, Zhang YM, Gao JM, Bai MS, Yang SX, Laatsch H, Zhang AL (2009) Bioactive
metabolites produced by Chaetomium globosum, an endophytic fungus isolated from Ginkgo
biloba. Bioorg Med Chem Lett 19:1572
224. Shanthiyaa V, Karthikeyan G, Raguchander T (2014) Production of extracellular proteins,
cellulases and antifungal metabolites by Chaetomium globosum Kunze ex. Fr. Arch
Phytopathol Plant Prot 47:517
225. Zhang G, Wang F, Qin J, Wang D, Zhang J, Zhang Y, Zhang S, Pan H (2013) Efficacy
assessment of antifungal metabolites from Chaetomium globosum No.05, a new biocontrol
agent, against Setosphaeria turcica. Biol Control 64:90
226. Flewelling AJ, Bishop AI, Johnson JA, Gray CA (2015) Polyketides from an endophytic
Aspergillus fumigatus isolate inhibit the growth of Mycobacterium tuberculosis and MRSA.
Nat Prod Commun 10:1661
227. Makioka A, Kumagai M, Kobayashi S, Takeuchi T (2004) Different effects of cytochalasins
on the growth and differentiation of Entamoeba invadens. Parasitol Res 93:68
228. Mori M, Tsuge S, Fukasawa W, Jeelani G, Nakada-Tsukui K, Nonaka K, Matsumoto A,
Omura S, Nozaki T, Shiomi K (2018) Discovery of antiamebic compounds that inhibit cysteine
synthase from the enteric parasitic protist Entamoeba histolytica by screening of microbial
secondary metabolites. Front Cell Infect Microbiol 8:409
229. Masi M, Cimmino A, Tabanca N, Becnel JJ, Bloomquist JR, Evidente A (2017) A survey of
bacterial, fungal and plant metabolites against Aedes aegypti (Diptera: Culicidae), the vector
of yellow and dengue fevers and Zika virus. Open Chem 15:156
230. Hu Y, hang W, Zhang P, Ruan W, Zhu X (2013) Nematicidal activity of chaetoglobosin A
produced by Chaetomium globosum NK102 against Meloidogyne incognita. J Agric Food
Chem 61:41